GSC
IONS icon

Ground Swell Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Ground Swell Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$547K Buy
+7,285
New +$575K 1.08% 19
2014
Q3 		– Sell
-1,774
Closed -$61K – 2575
2014
Q2 		$61K Buy
+1,774
New +$55.9K 0.12% 110

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ground Swell Capital's IONS Position: Q1 2026 in Review

Ground Swell Capital opened a new position in Ionis Pharmaceuticals (IONS) in Q1 2026: 7,285 shares worth $547K. The stake represents 1.08% of the portfolio and ranks #19 among its holdings. This is a return to the name: Ground Swell Capital previously reported a position in IONS as recently as Q2 2014.

Ground Swell Capital first reported a position in IONS in Q2 2014 and has held it in 2 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Ground Swell Capital held 7,285 shares of Ionis Pharmaceuticals worth $547K as of Q1 2026.
  • Ionis Pharmaceuticals was a new Ground Swell Capital position in Q1 2026.
  • Ionis Pharmaceuticals made up 1.08% of Ground Swell Capital's portfolio in Q1 2026, its #19 holding.
  • Ground Swell Capital first reported a position in Ionis Pharmaceuticals in Q2 2014 and has held it in 2 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Ground Swell Capital's 13F filing for Q1 2026, filed 21 Apr 2026.